ADYX (Adynxx) Cyclically Adjusted PB Ratio: (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADYX Adynxx Inc ADYX
16 GF Score
Price $0.00
View Full Analysis

What is Adynxx Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Adynxx  (OTCPK:ADYX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Adynxx Cyclically Adjusted PB Ratio Related Terms


Adynxx Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Adynxx's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adynxx Cyclically Adjusted PB Ratio Chart

Adynxx Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Adynxx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ADYX vs TRPX, MITI, RASP: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Adynxx's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adynxx Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adynxx's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Adynxx's Cyclically Adjusted PB Ratio falls into.


ADYX
16GF Score
Adynxx Inc ADYX
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adynxx Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Adynxx's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2019 is calculated as:

For example, Adynxx's adjusted Book Value per Share data for the three months ended in Sep. 2019 was:

Adj_Book=Book Value per Share/CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-1.905/256.7590*256.7590
=-1.905

Current CPI (Sep. 2019) = 256.7590.

Adynxx Quarterly Data

Book Value per Share CPI Adj_Book
200912 167.462 215.949 199.109
201003 50.846 217.631 59.988
201006 345.829 217.965 407.381
201009 336.921 218.439 396.026
201012 326.566 219.179 382.558
201103 315.911 223.467 362.975
201106 305.988 225.722 348.062
201109 297.675 226.889 336.864
201112 170.425 225.672 193.902
201203 157.375 229.392 176.150
201206 147.989 229.478 165.582
201209 139.837 231.407 155.157
201212 122.737 229.601 137.255
201303 108.426 232.773 119.599
201306 110.797 233.504 121.831
201309 96.127 234.149 105.409
201312 73.052 233.049 80.484
201403 53.823 236.293 58.485
201406 108.837 238.343 117.246
201409 96.748 238.031 104.360
201412 83.374 234.812 91.167
201503 60.468 236.119 65.754
201506 129.176 238.638 138.985
201509 118.447 237.945 127.812
201512 113.720 236.525 123.448
201603 102.476 238.132 110.492
201606 113.214 241.018 120.608
201609 98.261 241.428 104.501
201612 64.960 241.432 69.084
201703 47.736 243.801 50.273
201706 34.927 244.955 36.610
201709 32.561 246.819 33.872
201712 18.853 246.524 19.636
201803 12.560 249.554 12.923
201806 12.319 251.989 12.552
201809 11.441 252.439 11.637
201812 9.894 251.233 10.112
201903 8.856 254.202 8.945
201906 -1.593 256.143 -1.597
201909 -1.905 256.759 -1.905

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Adynxx Business Description

Address 100 Pine Street, Suite 500, San Francisco, CA, USA, 94111
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
16GF Score

Get the complete analysis for ADYX

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price